Medical Science Liaison, Tri-State Region, Hematology / Allergy

Territory: Eastern Pennsylvania, New Jersey, Delaware, Eastern Maryland

How will your role help us transform hope into reality?

The Medical Science Liaison is a field-based scientific and clinical expert who strategically supports the medical objectives of Blueprint Medicines’ development programs. The MSL is responsible for identifying, developing and managing peer-to-peer relationships with a variety of healthcare providers, including hematologists, allergists/immunologists, dermatologists, and oncologists in academic and community practices.

They will be accountable to engage in high quality scientific exchange about the science and clinical application of our precision medicine portfolio to variety of external stakeholders, as well as obtain important insights about current practice, treatment landscapes, and emerging clinical and scientific data. In addition, MSLs are expected to build strong cross-functional relationships, as well as provide meaningful subject-matter expertise, to colleagues in Medical Affairs, Clinical Research, R&D, Patient Advocacy and Commercial, while maintaining full compliance with all relevant company, industry, legal, and regulatory requirements. They will report to the Regional Director of MSLs.

What will you do?

• Identify key opinion leaders and cultivate a network of experts for Blueprint Medicines disease areas of focus


• Respond to unsolicited requests and engage in meaningful, peer-to-peer scientific exchange of complex medical and scientific information with the rare disease community


• Provide internal stakeholders with feedback and insights from interactions and discussions with HCPs


• Deliver medical/scientific presentations to internal & external stakeholders


• Assist with company-sponsored clinical trials and facilitation of investigator-initiated trials (ISTs)


• Lead planning and execution of regional advisory boards


• Collaborate with cross functional partners on internal projects and external initiatives


• Provide educational meeting support at scientific congresses


• Support training of cross functional teams


• Adhere to corporate and healthcare compliance guidance in all activities, including those related to clinical trials, scientific interactions with internal and external groups, and responses to unsolicited requests for medical/scientific information

What minimum qualifications do we require?

• Advanced Clinical/Science degree or professional credentials required (MD/DO, PhD, PharmD, NP, PA)


• 3 years of experience preferred in the biotech or pharmaceutical industry in Medical Affairs working with cross-functional in-house and field-based teams. Entry level MSL candidates with strong clinical backgrounds in rare disease, hematology, and/or allergy will also be considered.


• Extensive travel is required as part of this position (60%)

What additional qualifications will make you a stronger candidate?

• Ensure compliance with corporate rules and government regulations


• Strong analytical skills, especially with regard to understanding and interpreting scientific and clinical research and literature, are essential


• Hematology/Oncology, Allergy or Rare Disease experience strongly preferred


• Strong interpersonal, presentation and communication skills and demonstrated ability to work collaboratively in a dynamic, team-oriented environment


• Creative problem-solving skills


• Demonstrated self-starter and team player with strong interpersonal skills


• Adept, nimble, energetic and comfortable in a fast-paced, dynamic and collaborative environment


• Capable of taking a hands-on approach and willing to “roll up one’s sleeves.”


• Commitment to our Core Values: Patients First, Thoughtfulness, Urgency, Trust, Optimism

Why Blueprint?

At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators – the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success.

This is the place where the extraordinary becomes reality, and you could be part of it.

Patients are waiting. Are you ready to make the leap?

Equity, Diversity, Inclusion and Affirmative Action

At Blueprint Medicines, we foster a culture of equity, diversity and inclusion.  A proud Equal Employment Opportunity and Affirmative Action employer, we consider all qualified applicants without regard to race, color, sex, gender identity or expression, sexual orientation, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, or any other characteristic protected under applicable law.  We are also an E-Verify Employer.  We will make reasonable accommodations, absent undue hardship, for qualified individuals with known disabilities. If you are an individual with a disability in need of an accommodation with the application or recruiting process, please reach out to TotalRewards@blueprintmedicines.com. 

For more information, please see our EEO-AA Policy Statement, the EEO Know Your Rights Poster, as well as our Pay Transparency Statement. 

Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines, including bringing our medicine to patients with systemic mastocytosis (SM) in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including SM and chronic urticaria, breast cancer and other solid tumors.